Skip to main content
Haisco Pharmaceutical Group Co.,Ltd logo

Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 002653 ISIN · CNE100001BC7 LEI · 300300GRLH34A8GPJ639 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2023-08-08 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 002653

About Haisco Pharmaceutical Group Co.,Ltd

https://www.haisco.com

Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.

Recent filings

Filing Released Lang Actions
关于非公开发行限售股解除限售暨上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the lifting of restrictions on non-publicly issued restricted shares and their listing for circulation. It includes specifics about the number of shares, lock-up periods, shareholder commitments, changes in share capital structure, and regulatory approvals. The document is not a financial report, earnings release, or management discussion but rather a formal disclosure about share capital changes and share circulation status. This fits the category of Share Issue/Capital Change announcements, as it deals with the unlocking and listing of restricted shares, a capital structure event. The document length is under 5,000 characters but contains substantive details about share capital changes, so it is not merely a report publication announcement or a regulatory filing. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2023-08-08 Chinese
关于在中国香港设立全资子公司进展情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the establishment of a wholly-owned subsidiary in Hong Kong by the company. It includes details about the subsidiary's registration, capital, and business scope. There is no financial data, no mention of a report being attached or published, and no indication of a meeting or voting results. This is a corporate announcement about a capital structure change (setting up a new subsidiary), which fits best under Capital/Financing Update (CAP). The document length is short and focused on this update, not a report or regulatory filing.
2023-08-04 Chinese
关于控股股东部分股份质押展期的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the extension of a pledge on shares held by a controlling shareholder. It details the number of shares pledged, the pledge period extension, and related shareholder information. There is no financial report, earnings data, or management discussion. The content is about a shareholder's share pledge extension, which is a capital structure related update but specifically about share pledge extension rather than new financing or capital raising. This fits best under Capital/Financing Update (CAP) as it relates to financing activities involving share pledges by a controlling shareholder.
2023-08-02 Chinese
关于富马酸卢帕他定片通过仿制药一致性评价的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from 海思科医药集团股份有限公司 regarding the approval of a drug (富马酸卢帕他定片) passing the generic drug consistency evaluation by the National Medical Products Administration of China. It includes details about the drug, regulatory approval, and risk warnings. The document is short (1212 characters) and serves as an official announcement of regulatory approval rather than a financial report or detailed corporate filing. It does not contain financial statements, management discussion, or shareholder meeting information. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-08-01 Chinese
关于获得产业发展扶持资金的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company 海思科医药集团股份有限公司 regarding the receipt of industrial support funds (产业扶持资金). It details the amount, timing, accounting treatment, and expected impact on profits. The document is short (1294 characters) and focuses on a specific financing event related to government subsidies. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or interim reports. It is not a report itself but an announcement of a capital-related update. Therefore, it fits best under Capital/Financing Update (CAP).
2023-08-01 Chinese
关于对控股子公司减资暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related-party transaction involving capital reduction of a controlling subsidiary by the company. It details the transaction background, parties involved, financial data, approvals by the board and independent directors, and the need for shareholder approval. The document is a formal disclosure of a corporate action and related-party transaction, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but focuses on the announcement of the transaction and its approval process. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-07-25 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.